Venture 09 Full of Biotech

Tranzyme Pharma will join 14 other North Carolina biotech companies pitching their ideas at CED's Venture 2009 conference.

The RTP-based company develops products to treat gastrointestinal and metabolic diseases and is one of two featured presenters at the conference. The other is Peak10, a firm that provides data centers and has headquarters in Charlotte.

Tranzyme received a $150,000 small business research loan from the Biotechnology Center in 2003 to further its development efforts.

The state's other biotech companies taking the stage April 22-23 in Pinehurst are:
Companies that received financial support from the Biotechnology Center are labeled Portfolio Company

Late stage

  • Aldagen Inc. of Durham is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs.
  • Athenix Corp. of Research Triangle Park is a leading biotechnology company that develops novel products and technologies for agricultural and industrial applications, including biofuels and bioconversions. Portfolio Company

  • Biolex Therapeutics of Pittsboro is a clinical stage biopharmaceutical company that uses the LEX system to develop hard-to-make proteins and optimized monoclonal antibodies.
    Portfolio Company

  • Cempra Pharmaceuticals Inc. of Chapel Hilldevelops medicines for treating drug-resistant bacterial infections in the community and hospital.

  • Liquidia Technologies Inc. of Research Triangle Park utilizes its proprietary PRINT platform to design, develop, and manufacture precisely engineered particles and films for applications in engineered drug therapies and optical films.

  • nContact Surgical Inc. of Morrisville is developing a cardiac coagulation device for the treatment of arrhythmias of the heart.

  • PhaseBio Pharmaceuticals Inc. of Morrisville is developing biotherapeutics with a focus on the purification and delivery of proteins and peptides. Portfolio Company

Early Stage

  • Arbovax Inc. of Raleigh is an early stage company focused on commercialization of a novel technology to develop improved vaccines to prevent arthropod-borne diseases. Portfolio Company
  • Catena Pharmaceuticals Inc. of Durham is a drug discovery company developing proprietary anti-angiogenic G-protein coupled receptor (GPCR) antagonist compounds with a focus on in cancer and other proliferative diseases.
  • Contego Medical LLC

    Clinipace Inc. of Research Triangle Park is a clinical research software company that provides a single, integrated data capture and study management platform for post-approval research and registries.

  • Oncoscope Inc. of Durham develops optical imaging systems for guided biopsy in epithelial tissues in the esophagus, colon, lung, cervix, and bladder.

  • ParagonDx LLC of Morrisville develops and markets molecular diagnostic assays, analyte-specific reagents and diagnostic kits for personalized medicine applications.

  • Viamet Pharmaceuticals Inc. of Durham discovers and develops small molecule compounds that target metalloenzymes in the fields of infectious disease, inflammation and oncology.
    Portfolio Company

Over the past 25 years, CED's Venture conference has created business opportunities for hundreds of entrepreneurs and investors across North Carolina and the Southeast. As the nation's longest running financing event, CED's Venture 2009 showcases the region's most promising companies to an audience of top-tier investors and entrepreneurial leaders.

Early registration ends March 13.

Fri, 03/06/2009 - 05:00